SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 2.53 |
Enterprise Value ($M) | 3.41 |
Book Value ($M) | -1.49 |
Book Value / Share | -0.11 |
Price / Book | -1.70 |
NCAV ($M) | -1.49 |
NCAV / Share | -0.11 |
Price / NCAV | -1.70 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -175.88 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 0.00 |
Assets | 0.00 |
Liabilities | 1.49 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -0.64 |
Net Income | -0.79 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -0.07 |
Cash from Investing | 0.00 |
Cash from Financing | 0.07 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
PXYN – Praxsyn Corporation | PYRGF – PyroGenesis Canada Inc. |
QBIO – Q BioMed Inc. | RAPH – Raphael Pharmaceutical Inc. |
RASP – Actavia Life Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io